89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
9.43
+0.24 (2.61%)
At close: Aug 22, 2025, 4:00 PM
9.70
+0.27 (2.86%)
After-hours: Aug 22, 2025, 7:01 PM EDT
89bio Market Cap
89bio has a market cap or net worth of $1.40 billion as of August 22, 2025. Its market cap has increased by 71.27% in one year.
Market Cap
1.40B
Enterprise Value
875.00M
1-Year Change
71.27%
Ranking
Category
Stock Price
$9.43
Market Cap Chart
Since November 12, 2019, 89bio's market cap has increased from $256.62M to $1.40B, an increase of 444.99%. That is a compound annual growth rate of 34.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1.40B | 52.10% |
| Dec 31, 2024 | 919.49M | -11.68% |
| Dec 29, 2023 | 1.04B | 75.74% |
| Dec 30, 2022 | 592.42M | 123.48% |
| Dec 31, 2021 | 265.09M | -45.28% |
| Dec 31, 2020 | 484.45M | 33.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |